"The Effect of Stellate Ganglion Block in Severe Brain Injury"
1 other identifier
interventional
40
1 country
1
Brief Summary
Blood flow through the brain is reduced after brain damage. Secondary brain ischemia caused by hypoxia and hypotension, further increase the susceptibility of the ischemically compromised brain to secondary impairment during this period. In order to determine whether and to what extent blockage of the stellate ganglion (BSG) affects the blood flow to the injured brain, the investigators will measure the variables of brain blood flow before and after BSG using computed tomography angiography (CTA), trans-cranial Doppler ultrasound (TCD), intracranial pressure (ICP) and perfusion computed tomography (PCT) of the brain. At the same time, the investigators would like to evaluate whether and to what extent BSG affects the aseptic inflammatory brain injury response and the biochemical indicators of brain damage in patients with moderate and severe brain injury.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 21, 2019
CompletedFirst Posted
Study publicly available on registry
December 23, 2019
CompletedStudy Start
First participant enrolled
November 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedJanuary 3, 2024
December 1, 2023
2.2 years
November 21, 2019
December 30, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in diameter of the cerebral arteries
Diameters of the cerebral arteries will be measured in millimeters (mm) on the CTA before and after BSG. Measurement of the diameter will be done on standard positions: middle third of M1 segment and upper part of M2 segment of middle cerebral artery, middle third of A1 and A2 segment of anterior cerebral artery, P1 segment and first part of P2 segment of posterior cerebral artery, terminal part of internal carotid artery, middle third of the intradural part of vertebral artery and middle third of basilar artery.
First measurement of the diameter will be done on the CTA made during the first week of hospitalization. Control measurement will be done 1 hour after the BSG.
Secondary Outcomes (12)
Change of mean transition time (MTT) on perfusion computed tomography.
Indicators will be measured 1 hour after the BSG
Change of regional cerebral blood flow (rCBF) on perfusion computed tomography.
Measurement will be measured 1 hour after the BSG
Change of regional cerebral blood volume (rCBV) on perfusion computed tomography.
Measurement will be measured 1 hour after the BSG
Change of systolic velocity (sV) on transcranial Doppler ultrasound
Measurement will be made one hour before and one hour after the BSG.
Change of diastolic velocity (dV) on transcranial Doppler ultrasound
Measurement will be made one hour before and one hour after the BSG.
- +7 more secondary outcomes
Study Arms (1)
BSG patients
EXPERIMENTALInterventions
Ultrasound guided one site blockade of the stellate ganglion.
Eligibility Criteria
You may qualify if:
- patients with moderate and severe head injury
- patients who underwent computed tomograply angiography of the brain (CTA) at admission to the UKC Ljubljana Emergency Center or during CIT treatment
- patients with intra-parenchymal intracranial pressure monitor electrode (ICP) installed
You may not qualify if:
- patients with primary decompression craniectomy
- radiological signs of progression of intracranial hematomas
- barbiturate coma
- patients with a norepinephrine dose greater than 0.2 mcg/kg/min
- pregnant women
- children
- known hypersensitivity to iodine contrast media and local anesthetics
- poor renal function (estimated glomerular filtration below 30ml / min / 1.73m2).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ivan Kostadinov
Ljubljana, 1000, Slovenia
Related Publications (1)
Kostadinov I, Avsenik J, Osredkar J, Jerin A, Gradisek P. Effect of stellate ganglion block on brain hemodynamics and the inflammatory response in moderate and severe traumatic brain injury: a pilot study. Reg Anesth Pain Med. 2025 Feb 19:rapm-2024-106185. doi: 10.1136/rapm-2024-106185. Online ahead of print.
PMID: 39971387DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- asist Ivan Kostadinov, dr.med.EDRA
Study Record Dates
First Submitted
November 21, 2019
First Posted
December 23, 2019
Study Start
November 1, 2021
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
January 3, 2024
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR, ANALYTIC CODE
- Time Frame
- 2 years